2015-05-08T13:02:15-05:00 2014-12-31 ERNST & YOUNG US LLP TWO NORTH CENTRAL AVENUE STE 2300 PHOENIX AZ 85004 990 2014-01-01 271120123 CREATIVE TESTING SOLUTIONS % SUSAN L BARNES CFO CREA 6023437016 6210 EAST OAK STREET Suite SCOTTSDALE AZ 85257 SUSAN BARNES EXECUTIVE VP & CFO 2015-05-07 BRENDA GRIESEMER P00264669 2014 2016-02-25 16:41:14Z SALLY CAGLIOTI 6210 EAST OAK STREET SCOTTSDALE AZ 85257 218449490 false X WWW.MYCTS.ORG X 2009 AZ TO PROVIDE EXCEPTIONAL CUSTOMIZED LABORATORY TESTING SERVICES TO SUPPORT THE HOSPITALS AND OTHER HEALTHCARE ORGANIZATIONS WITH THEIR LIFE SAVING MISSIONS. 11 9 483 5 260002 -77438 0 0 223773336 217463656 674717 985834 600343 0 225048396 218449490 1522632 1253275 0 0 37367898 38461312 0 0 0 182084464 163580670 220974994 203295257 4073402 15154233 73380094 90812035 22328470 23909281 51051624 66902754 X TO PROVIDE EXCEPTIONAL CUSTOMIZED LABORATORY TESTING SERVICES TO SUPPORT THE HOSPITALS AND OTHER HEALTHCARE ORGANIZATIONS WITH THEIR LIFE SAVING MISSIONS. false false 180909039 1253275 216121211 TESTING OF BLOOD SAMPLES RECEIVED FROM VOLUNTEER BLOOD DONORS PROVIDED IN CONJUNCTION WITH BLOOD DONATIONS AT NOT-FOR-PROFIT BLOOD CENTERS THROUGHOUT THE COUNTRY AS WELL AS HOSPITALS AND OTHER ORGANIZATIONS, AS REQUIRED BY THE FOOD AND DRUG ADMINISTRATION. SEE SCHEDULE O FOR FURTHER DETAIL. 839005 0 1342445 THE CTS RESEARCH PROGRAM IS DEDICATED TO ADVANCING BLOOD SAFETY AND EVIDENCE-BASED TRANSFUSION PRACTICES THROUGH SCIENTIFIC RESEARCH. SEE SCHEDULE O FOR FURTHER DETAIL. 181748044 true false false false false false false false false false true false false false false true true true false false false false false false false false false true false true false false false false false false true false false false false false false true true true false false true 32 0 true 483 true false false false false false false X 11 9 false false false false true true true true true false false true true true true true false false false false AZ X SUSAN L BARNES CFO 4806755696 6210 EAST OAK STREET SCOTTSDALE AZ 85257 JAMES P AUBUCHON MD TRUSTEE 1.0 0.0 X 0 0 0 SUSAN BARNES TRUSTEE/CFO 10.0 40.0 X X 0 300354 17113 J DANIEL CONNOR TRUSTEE 2.0 38.0 X 0 609344 40549 JAMES P COVERT TRUSTEE 1.0 0.0 X 0 0 0 DONALD D DODDRIDGE TRUSTEE 2.0 0.0 X 0 0 0 WILLIAM G GREEN TRUSTEE/SECRETARY/TREASURER 1.0 4.0 X X 0 30000 0 KATHLEEN S PUSHOR TRUSTEE 1.0 3.0 X 0 24750 0 CHRIS STILES TRUSTEE/VICE CHAIR 1.0 0.0 X X 0 0 RON WAECKERLIN MD TRUSTEE 1.0 3.0 X 0 35750 0 RICK WALSH TRUSTEE 1.0 0.0 X 0 0 0 GARY K WILDE TRUSTEE/CHAIR 1.0 3.0 X X 0 24250 0 SALLY CAGLIOTI PRESIDENT 40.0 0.0 X 342401 0 15565 EUGENE ROBERTSON PHD VICE PRESIDENT 40.0 0.0 X 243329 0 26463 GERMAN LEPARC MD CHIEF MEDICAL OFFICER 20.0 0.0 X 209826 0 28568 BHAVI SHAH ASSISTANT SECRETARY 10.0 30.0 X 0 210596 19742 MARC PEARCE VICE PRESIDENT 40.0 0.0 X 209832 0 18739 PHILLIP WILLIAMSON PHD VICE PRESIDENT 40.0 0.0 X 206890 0 20261 MORRIS DIXON DIRECTOR (THRU 12/14) 40.0 0.0 X 187084 0 15398 JOAN DUNN-WILLIAMS DIRECTOR 40.0 0.0 X 182551 0 17636 Michael Phillips DIRECTOR 40.0 0.0 X 152547 0 29243 SHERYL J CYRUS DIRECTOR 40.0 0.0 X 148794 0 22756 NANCY L HAUBERT DIRECTOR 40.0 0.0 X 146143 0 22134 2029397 1235044 294167 26 false true true MEDIWARE INFORMATION SYSTEMS INC 11711 W 79TH STREET LENEXA KY 66214 INFO TECH CONSULTANT 736338 FEDEX PO BOX 94515 PALATINE IL 60094 DELIVERY SERVICE 484555 MIDNITE EXPRESS DEPT 8255 LOS ANGELES CA 90084 DELIVERY SERVICE 374542 SOUTHWEST AIRLINES CARGO PO BOX 97390 DALLAS TX 75397 DELIVERY SERVICE 305809 CH ROBINSON COMPANY PO BOX 9121 MINNEAPOLIS MN 55480 DELIVERY SERVICE 236051 5 0 LABORATORY SERVICES 621500 215861209 215861209 RESEARCH & DEVELOPMENT SUPPORT 541700 1342445 1342445 LABORATORY MANAGEMENT SERVICE FEE 541611 260002 260002 217463656 790244 790244 0 0 0 0 0 195590 195590 195590 195590 0 0 0 0 218449490 217203654 260002 985834 1253275 1253275 0 0 0 1083479 1083479 59107 59107 28484498 21391858 7092640 2894351 2173658 720693 3896478 2926255 970223 2043399 1534593 508806 6893155 6893155 215831 215831 15000 15000 0 0 10953 10953 325348 99722 225626 0 6046602 5830906 215696 1296828 1018224 278604 0 3545087 880671 2664416 353914 12853 341061 0 0 0 0 37065 299 36766 302101 302101 PROCESSING AND OPER SUPPLIES 139441233 139441233 POSTAGE, FREIGHT & COURIER 3378500 3363774 14726 BUSINESS LICENSING & TAX 198381 82693 115688 DONOR RECRUITMENT 54556 54556 1466116 1322266 143850 203295257 181748044 21547213 0 12361062 23632757 25478715 32317650 0 0 26018740 28304813 0 0 0 0 181272 0 8163935 4697523 747690 561522 1831642 633872 328680 1197770 0 0 0 0 0 0 0 0 100000 100000 73380094 90812035 22328470 23909281 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 22328470 23909281 X 51051624 66902754 0 0 0 0 51051624 66902754 73380094 90812035 15154233 696897 X false true X true false X 1319238 633872 685366 512404 512404 1197770 0 0 X 219146387 696897 696897 218449490 218449490 203295257 203295257 203295257 Schedule D, Part X, Line 2 AT DECEMBER 31, 2014 AND 2013, THE COMPANY EVALUATED WHETHER IT HAD UNCERTAIN TAX POSITIONS THAT SHOULD BE RECOGNIZED OR DERECOGNIZED BASED ON A 'MORE LIKELY THAN NOT' THRESHOLD FOR TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, INCLUDING THOSE TAX POSITIONS THAT WOULD NOT BE SUSTAINED UPON EXAMINATION IN ACCORDANCE WITH GUIDANCE RELATED TO ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. THE TAX YEARS FOR THE COMPANY THAT ARE OPEN TO AUDIT BY THE IRS AND STATE DEPARTMENTS OF REVENUE ARE THE TAX YEARS ENDED DECEMBER 31, 2011, THROUGH THE CURRENT TAX YEAR. AS OF DECEMBER 31, 2014 AND 2013, THE COMPANY HAS NOT IDENTIFIED ANY UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE THE RECORDING OF A TAX LIABILITY. THE COMPANY DOES NOT ANTICIPATE A CHANGE IN UNCERTAIN TAX POSITIONS FOR THE 12 MONTHS FOLLOWING THE YEAR ENDED DECEMBER 31, 2014. true BLOOD SYSTEMS INC 6210 EAST OAK STREET SCOTTSDALE AZ 85257 860098929 501(C)(3) 1239005 TO BSRI FOR FURTHER RESEARCH 1 SCHEDULE I, PART I, LINE 2 CREATIVE TESTING SOLUTIONS RELIES ON BLOOD SYSTEMS, INC.'S GOOD GOVERNANCE AND OPERATIONAL PROCEDURES TO SPEND THE MONEY AS INTENDED. false true false false false false false false false SUSAN BARNES TRUSTEE/CFO 0 289654 0 0 0 10700 0 10400 0 6713 0 317467 0 0 J DANIEL CONNOR TRUSTEE 0 597644 0 0 0 11700 0 27900 0 12649 0 649893 0 0 SALLY CAGLIOTI PRESIDENT 331701 0 0 0 10700 0 9067 0 6498 0 357966 0 0 0 EUGENE ROBERTSON PHD VICE PRESIDENT 233729 0 0 0 9600 0 9861 0 16602 0 269792 0 0 0 MARC PEARCE VICE PRESIDENT 200232 0 0 0 9600 0 7813 0 10926 0 228571 0 0 0 PHILLIP WILLIAMSON PHD VICE PRESIDENT 197290 0 0 0 9600 0 8329 0 11932 0 227151 0 0 0 GERMAN LEPARC MD CHIEF MEDICAL OFFICER 195020 0 10000 0 4806 0 13650 0 14918 0 238394 0 0 0 MORRIS DIXON DIRECTOR (THRU 12/14) 179584 0 0 0 7500 0 5895 0 9503 0 202482 0 0 0 JOAN DUNN-WILLIAMS DIRECTOR 175051 0 0 0 7500 0 5812 0 11824 0 200187 0 0 0 Michael Phillips DIRECTOR 145047 0 0 0 7500 0 23688 0 5555 0 181790 0 0 0 SHERYL J CYRUS DIRECTOR 141294 0 0 0 7500 0 6149 0 16607 0 171550 0 0 0 NANCY L HAUBERT DIRECTOR 138643 0 0 0 7500 0 5931 0 16203 0 168277 0 0 0 BHAVI SHAH ASSISTANT SECRETARY 0 180307 0 20000 0 10289 0 5835 0 13907 0 230338 0 0 SCHEDULE J, PART I, LINE 3 CREATIVE TESTING SOLUTIONS RELIES ON THE METHODS USED BY BLOOD SYSTEMS, INC. (BSI) IN ESTABLISHING COMPENSATION PAID TO THE PRESIDENT INCLUDING: COMPENSATION COMMITTEE, INDEPENDENT COMPENSATION CONSULTANT, COMPENSATION SURVEY OR STUDY, AND APPROVAL BY THE BOARD OR COMPENSATION COMMITTEE OF CREATIVE TESTING SOLUTIONS. SCHEDULE J, PART I, LINE 4B THERE WERE NO DISTRIBUTIONS FROM THE SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN DURING 2014 TO ANY INDIVIDUALS REPORTED ON FORM 990, PART VII. THIS PLAN WAS FROZEN AS OF DECEMBER 31, 2011. SCHEDULE J, PART II GERMAN LEPARC MD IS PAID BY ONEBLOOD, A MINORITY MEMBER OF CREATIVE TESTING SOLUTIONS (CTS), AND SPLITS HIS TIME BETWEEN CTS AND ONEBLOOD. THE REPORTED AMOUNTS REPRESENT TOTAL COMPENSATION FOR SERVICES RENDERED TO BOTH ORGANIZATIONS. BHAVI SHAH RECIEVED A ONE-TIME HIRING BONUS, WHICH IS INCLUDED IN SCHEDULE J, PART II, COLUMN B(II). MICHAEL LEPARC SON OF OFFICER 59107 EMPLOYEE COMPENSATION false FORM 990, PART III, LINES 4A AND 4B 4A) DONOR TESTING BLOOD DONOR TESTING SERVICES PROVIDED BY CREATIVE TESTING SOLUTIONS ARE ESSENTIAL TO ENSURING THE SAFETY OF THE NATION'S BLOOD SUPPLY. THESE TESTING ACTIVITIES ARE ABSOLUTELY NECESSARY AND MANDATED BY THE UNITED STATES FOOD AND DRUG ADMINISTRATION ("FDA") TO PROVIDE A SAFE BLOOD PRODUCT FOR TRANSFUSION TO PATIENTS. DUE TO THE SIGNIFICANT HEALTH RISKS ASSOCIATED WITH THE USE OF HUMAN BLOOD AND BLOOD COMPONENTS, IT IS CRITICAL FOR PUBLIC SAFETY PURPOSES THAT BLOOD BE PROPERLY TESTED BEFORE BEING INTRODUCED INTO THE HEALTHCARE SYSTEM FOR USE BY PATIENTS. A SAFE BLOOD SUPPLY IS CRITICAL TO THE WELL-BEING OF THE NATION'S HEALTHCARE SYSTEM AND ITS PATIENTS. THE SIGNIFICANCE OF THE TESTING OF BLOOD FOR PUBLIC SAFETY IS EVEN MORE PRONOUNCED IN THIS AGE OF THREATS FROM PANDEMICS AND TERRORISM. CREATIVE TESTING SOLUTIONS HAS FOUR DONOR TESTING LABORATORIES (DTL). OUR FIRST ESTABLISHED LABORATORY IS IN TEMPE, ARIZONA. THE ADDITIONAL LABORATORIES ARE LOCATED IN BEDFORD, TEXAS; ROSEMONT, ILLINOIS; AND ST. PETERSBURG, FLORIDA. THESE LOCATIONS ARE STRATEGICALLY POSITIONED NEAR MAJOR AIRPORTS IN PHOENIX, DALLAS, CHICAGO AND TAMPA. ALL FOUR DTL LABORATORIES ARE FOOD AND DRUG ADMINISTRATION (FDA) REGISTERED FACILITIES AND HOLD CURRENT CERTIFICATIONS FOR THE CLINICAL LABORATORY IMPROVEMENT ACT (CLIA) AS WELL AS ACCREDITATION WITH THE AMERICAN ASSOCIATION OF BLOOD BANKS (AABB), THE NEW YORK STATE DEPARTMENT OF HEALTH, CALIFORNIA DEPARTMENT OF HEALTH SERVICES AND STATE OF FLORIDA AGENCY FOR HEALTH CARE ADMINISTRATION. IN ADDITION TO DONOR SPECIMEN TESTING, THE LABORATORIES PARTICIPATE IN CLINICAL EVALUATION OF REAGENTS, TEST KITS, AND EQUIPMENT. CTS PROVIDES THE HIGHEST QUALITY IN TESTING AND SERVICE. THE LABORATORIES MAINTAIN INTERNAL QUALITY CONTROL PROGRAMS AND PARTICIPATE VOLUNTARILY IN EXTERNAL QUALITY CONTROL PROGRAMS. BLOOD SPECIMENS ARE PROCESSED UTILIZING STATE OF THE ART TECHNOLOGY WITH FDA LICENSED TEST KITS AND REAGENTS. ALL LABORATORIES ARE EQUIPPED WITH MULTIPLE AND REDUNDANT INSTRUMENTS REQUIRED FOR ROUTINE PROCESSING. ADDITIONALLY, EACH FACILITY ACTS AS A BACKUP LABORATORY TO THE OTHER THREE LABS. SPECIAL TESTING OUR SPECIAL TESTING LABORATORIES IN THE PHOENIX AND TAMPA AREAS PERFORM CONFIRMATORY AND SUPPLEMENTAL TESTING OF DONOR SAMPLES AS WELL AS NON-DONATION TESTING SUCH AS DONOR RE-ENTRY, POST EXPOSURE AND DONOR FOLLOW-UP. WE ALSO PROVIDE TESTING FOR EYE BANKS, TISSUE BANKS AND CORD BLOOD CENTERS. THE SPECIAL TESTING LABORATORY ALSO COMPLIES WITH CLIA, FDA, CA, NY, MD, AND FL STATE REGULATIONS. COMPONENT QUALITY CONTROL OUR COMPONENT QUALITY CONTROL LABORATORY IN PHOENIX PROVIDES BLOOD COMPONENT QUALITY CONTROL TESTING. RESIDUAL WHITE BLOOD CELL (RWBC) COUNTS ARE PERFORMED ON LEUKOREDUCED PRODUCTS. FACTOR VIII AND FIBRINOGEN ASSAYS ARE PERFORMED ON CRYOPRECIPITATE AND PLASMA PRODUCTS. BACTERIAL DETECTION IS PERFORMED ON APHERESIS PLATELETS. 4B) RESEARCH AND DEVELOPMENT THE CTS RESEARCH PROGRAM FOCUSES ON THE DEVELOPMENT AND/OR EVALUATION OF NEW BLOOD DONOR SCREENING TECHNOLOGIES WHICH SIGNIFICANTLY IMPROVE AND PROMOTE BLOOD SAFETY IN THE AREAS OF INFECTIOUS DISEASE, IMMUNOLOGY, MOLECULAR DIAGNOSTICS, AND EPIDEMIOLOGY. ADDITIONALLY, THE CTS RESEARCH PROGRAM SERVES AS THE FOCUS FOR A MULTI-INSTITUTIONAL CONSORTIUM WHICH INTEGRATES DATA FROM APPROXIMATELY 35% OF THE US BLOOD SUPPLY FOR THE PURPOSE OF DRIVING THE EVALUATION OF BEST PRACTICES IN TRANSFUSION MEDICINE, THE PROMOTION OF DONOR HEALTH, AND THE IMPROVEMENT OF TRANSFUSION RECIPIENT OUTCOMES. FORM 990, PART VI, LINE 6 CREATIVE TESTING SOLUTIONS HAS FOUR NONPROFIT CORPORATE MEMBERS: BLOOD SYSTEMS, INC., THE INSTITUTE FOR TRANSFUSION MEDICINE ("ITxM"), PUGET SOUND BLOOD CENTER ("PSBC") AND ONEBLOOD, INC. FORM 990, PART VI, LINE 7A THE BOARD OF DIRECTORS CONSISTS OF NO LESS THAN 11 AND NO MORE THAN 17 DIRECTORS APPOINTED BY THE MEMBERS (BLOOD SYSTEMS, INC., THE INSTITUTE FOR TRANSFUSION MEDICINE, ONEBLOOD, INC., AND PUGET SOUND BLOOD CENTER). BLOOD SYSTEMS, INC. SHALL BE ENTITLED TO DESIGNATE A MAJORITY OF THE NUMBER OF DIRECTORS AT ALL TIMES. FORM 990, PART VI, LINE 7B CERTAIN ACTIONS AND DECISIONS OF THE CORPORATION REQUIRE PRIOR UNANIMOUS APPROVAL FROM EACH OF THE FOUR MEMBERS (BLOOD SYSTEMS, INC., ITxM, PUGET SOUND BLOOD CENTER, AND ONEBLOOD, INC.) PER THE BYLAWS. FORM 990, PART VI, LINE 11B THE FORM 990 IS PREPARED BY AN OUTSIDE ACCOUNTING FIRM BASED ON INFORMATION PROVIDED BY THE CFO AND THE FINANCE TEAM. A COPY OF THE DRAFT FORM 990 AND SCHEDULES IS SUPPLIED TO ALL BOARD MEMBERS PRIOR TO THE MEETING HELD TO ACCEPT THE RETURNS. MEMBERS OF MANAGEMENT REVIEW THE FORM 990 WITH THE BOARD AND ARE AVAILABLE FOR ANSWERING QUESTIONS. ANY COMMENTS FROM THE BOARD ARE CONSIDERED PRIOR TO FILING THE FORM 990 WITH THE IRS. FORM 990, PART VI, LINE 12C EACH YEAR, THE BOARD OF DIRECTORS AND SENIOR MANAGEMENT ARE REQUIRED TO SIGN AND RETURN A CONFLICT OF INTEREST FORM TO COMPANY COUNSEL. ANY CONFLICTS DISCLOSED ARE DISCUSSED IN EXECUTIVE SESSION WITH THE BOARD AND RESOLVED. IN ADDITION, IN PREPARATION FOR THE FORM 990 FILING, THE DIRECTORS, OFFICERS AND KEY EMPLOYEES IDENTIFIED ARE REQUIRED TO RESPOND TO A COMPREHENSIVE CONFLICT OF INTEREST AND FAMILY RELATIONSHIP QUESTIONNAIRE. ANY CONFLICTS DISCLOSED ARE DISCUSSED WITH THE BOARD AND DISCLOSED APPROPRIATELY ON THE FORM 990. FORM 990, PART VI, LINE 14 BLOOD SYSTEMS, INC. (BSI) MAINTAINS THE RECORDS OF CREATIVE TESTING SOLUTIONS (CTS). SINCE CTS MAINTAINS NO RECORDS, IT HAS NOT ADOPTED A DOCUMENT RETENTION AND DESTRUCTION POLICY ITSELF. INSTEAD CTS RECORDS ARE MAINTAINED UNDER THE DOCUMENT RETENTION AND DESTRUCTION POLICY OF BSI. FORM 990, PART VI, LINE 15A AND 15B CREATIVE TESTING SOLUTION RELIES ON THE METHODS USED BY BSI IN ESTABLISHING COMPENSATION PAID TO THE PRESIDENT INCLUDING: COMPENSATION COMMITTEE, INDEPENDENT COMPENSATION CONSULTANT, COMPENSATION SURVEY OR STUDY, AND APPROVAL BY THE BOARD OR COMPENSATION COMMITTEE OF CREATIVE TESTING SOLUTIONS. FORM 990, PART VI, LINE 19 THE FORM 990 IS MADE AVAILABLE ON THE COMPANY'S INTRA-NET FOR ALL OPERATING LOCATIONS TO ACCESS. UPON REQUEST, THE FORM CAN BE PRINTED OR VIEWED ON-LINE. UPON WRITTEN REQUEST TO THE CHIEF FINANCIAL OFFICER, A COPY OF THE FORM 990 WILL BE MAILED TO THE REQUESTOR. THE GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE NOT MADE AVAILABLE TO THE PUBLIC. THE ORGANIZATION'S COMBINED FINANCIAL STATEMENTS ARE MADE PUBLIC VIA THE ANNUAL REPORT POSTED ON THE BLOOD SYSTEMS' WEBSITE. BLOOD SYSTEMS INC 6210 E OAK STREET SCOTTSDALE AZ 85257 860098929 BLOOD BANKING AZ 501(C)(3) 9 NA false INLAND NORTHWEST BLOOD CENTER 210 W CATALDO AVENUE SPOKANE WA 99201 910499130 BLOOD BANKING WA 501(C)(3) 9 BSI true BLOOD CENTERS OF THE PACIFIC 270 MASONIC AVENUE SAN FRANCISCO CA 94118 941156555 BLOOD BANKING CA 501(C)(3) 9 BSI true BELLE BONFILS MEMORIAL BLOOD CENTER 717 Yosemite STREET DENVER CO 80230 840411209 Blood Banking CO 501(C)(3) 9 BSI true BLOOD BANK OF SAN BERNARDINO & RIVERSIDE PO BOX 1429 SAN BERNARDINO CA 92402 951708743 BLOOD BANKING CA 501(C)(3) 9 BSI true CANYON STATE INSURANCE COMPANY WEST BAY ROAD GRAND CAYMAN CJ INVESTMENT CJ NA FOREIGN false true false false false false false false false false true true true false false true false false false BELLE BONFILS MEMORIAL BLOOD CENTER L 4107858 ACCRUAL BLOOD CENTERS OF THE PACIFIC L 3868390 ACCRUAL BLOOD BANK OF SAN BERNARDINO & RIVERSIDE L 2764855 ACCRUAL INLAND NORTHWEST BLOOD CENTER L 2087017 ACCRUAL